154 related articles for article (PubMed ID: 18361501)
1. Systematic exploration of active site mutations on human deoxycytidine kinase substrate specificity.
Iyidogan P; Lutz S
Biochemistry; 2008 Apr; 47(16):4711-20. PubMed ID: 18361501
[TBL] [Abstract][Full Text] [Related]
2. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .
Hazra S; Ort S; Konrad M; Lavie A
Biochemistry; 2010 Aug; 49(31):6784-90. PubMed ID: 20614893
[TBL] [Abstract][Full Text] [Related]
3. Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase.
Hazra S; Sabini E; Ort S; Konrad M; Lavie A
Biochemistry; 2009 Feb; 48(6):1256-63. PubMed ID: 19159229
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence energy transfer studies of human deoxycytidine kinase: role of cysteine 185 in the conformational changes that occur upon substrate binding.
Mani RS; Usova EV; Cass CE; Eriksson S
Biochemistry; 2006 Mar; 45(11):3534-41. PubMed ID: 16533034
[TBL] [Abstract][Full Text] [Related]
6. Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.
Johnsamuel J; Eriksson S; Oliveira M; Tjarks W
Bioorg Med Chem; 2005 Jul; 13(13):4160-7. PubMed ID: 15876539
[TBL] [Abstract][Full Text] [Related]
7. Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release.
Hazra S; Szewczak A; Ort S; Konrad M; Lavie A
Biochemistry; 2011 Apr; 50(14):2870-80. PubMed ID: 21351740
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of different binding modes of purine nucleosides to human deoxycytidine kinase.
Sabini E; Hazra S; Konrad M; Lavie A
J Med Chem; 2008 Jul; 51(14):4219-25. PubMed ID: 18570408
[TBL] [Abstract][Full Text] [Related]
9. Structure of human dCK suggests strategies to improve anticancer and antiviral therapy.
Sabini E; Ort S; Monnerjahn C; Konrad M; Lavie A
Nat Struct Biol; 2003 Jul; 10(7):513-9. PubMed ID: 12808445
[TBL] [Abstract][Full Text] [Related]
10. The effects of high salt concentrations on the regulation of the substrate specificity of human recombinant deoxycytidine kinase.
Usova EV; Eriksson S
Eur J Biochem; 1997 Sep; 248(3):762-6. PubMed ID: 9342227
[TBL] [Abstract][Full Text] [Related]
11. The sugar ring of the nucleoside is required for productive substrate positioning in the active site of human deoxycytidine kinase (dCK): implications for the development of dCK-activated acyclic guanine analogues.
Hazra S; Konrad M; Lavie A
J Med Chem; 2010 Aug; 53(15):5792-800. PubMed ID: 20684612
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs.
Eriksson S; Kierdaszuk B; Munch-Petersen B; Oberg B; Johansson NG
Biochem Biophys Res Commun; 1991 Apr; 176(2):586-92. PubMed ID: 2025274
[TBL] [Abstract][Full Text] [Related]
13. Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues.
McSorley T; Ort S; Hazra S; Lavie A; Konrad M
FEBS Lett; 2008 Mar; 582(5):720-4. PubMed ID: 18258203
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the preference of UTP over ATP in human deoxycytidine kinase: illuminating the role of main-chain reorganization.
Godsey MH; Ort S; Sabini E; Konrad M; Lavie A
Biochemistry; 2006 Jan; 45(2):452-61. PubMed ID: 16401075
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues involved in the substrate specificity of human and murine dCK.
Usova EV; Eriksson S
Biochem Pharmacol; 2002 Dec; 64(11):1559-67. PubMed ID: 12429345
[TBL] [Abstract][Full Text] [Related]
16. Redesigning human 2'-deoxycytidine kinase enantioselectivity for L-nucleoside analogues as reporters in positron emission tomography.
Muthu P; Chen HX; Lutz S
ACS Chem Biol; 2014 Oct; 9(10):2326-33. PubMed ID: 25079348
[TBL] [Abstract][Full Text] [Related]
17. A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: a model for nucleoside kinase action.
Turk B; Awad R; Usova EV; Björk I; Eriksson S
Biochemistry; 1999 Jun; 38(26):8555-61. PubMed ID: 10387103
[TBL] [Abstract][Full Text] [Related]
18. Low enantioselectivities of human deoxycytidine kinase and human deoxyguanosine kinase with respect to 2'-deoxyadenosine, 2'-deoxyguanosine and their analogs.
Gaubert G; Gosselin G; Boudou V; Imbach JL; Eriksson S; Maury G
Biochimie; 1999 Nov; 81(11):1041-7. PubMed ID: 10575360
[TBL] [Abstract][Full Text] [Related]
19. Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity.
Smal C; Vertommen D; Amsailale R; Arts A; Degand H; Morsomme P; Rider MH; Neste EV; Bontemps F
Arch Biochem Biophys; 2010 Oct; 502(1):44-52. PubMed ID: 20637175
[TBL] [Abstract][Full Text] [Related]
20. Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2).
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Adv Exp Med Biol; 1998; 431():623-7. PubMed ID: 9598140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]